METHOD FOR RAPIDLY DETERMINING SURVIVAL CONDITION OF SPORES

    公开(公告)号:US20240417773A1

    公开(公告)日:2024-12-19

    申请号:US18689866

    申请日:2023-04-11

    Abstract: The present disclosure discloses a method for rapidly determining survival condition of spores. The method includes the following steps: S100: performing sterilization treatment on the spore; S200: preparing a spore suspension with the spore subjected to the sterilization treatment; S300: dripping an appropriate amount of the above prepared spore suspension onto a solid medium, wherein 4-MUG is contained in the solid medium; S400: observing the solid medium under an excitation light source after the spore suspension fully infiltrates into the solid medium; and S500: determining the number of viable spores according to the number of the observed fluorescent spots on the solid medium. The method is based on an α-glucosidase test method and can rapidly determine activity of the spore and judge activity of a single spore.

    Use of non-coding RNA SNHG17 as biomarker and therapeutic target

    公开(公告)号:US11866707B2

    公开(公告)日:2024-01-09

    申请号:US18048451

    申请日:2022-10-21

    CPC classification number: C12N15/1135 A61P43/00 C12N2310/122

    Abstract: This invention discloses the use of non-coding RNA SNHG17 as a biomarker and a therapeutic target that relates to the technical field of tumor biotherapy. This invention discloses a use of the non-coding RNA SNHG17 for the manufacture of a detection agent for predicting the drug resistance of fulvestrant. This invention also discloses the use of shRNA for inhibiting non-coding RNA SNHG17 expression. This shRNA can knockdown the expression of the non-coding RNA SNHG17 efficiently. In this way, the sensitivity of fulvestrant-resistant breast cancer cells can be increased. So this invention has good prospects for drug development.

    USE OF NON-CODING RNA SNHG17 AS BIOMARKER AND THERAPEUTIC TARGET

    公开(公告)号:US20230374516A1

    公开(公告)日:2023-11-23

    申请号:US18048451

    申请日:2022-10-21

    CPC classification number: C12N15/1135 A61P43/00 C12N2310/122

    Abstract: This invention discloses the use of non-coding RNA SNHG17 as a biomarker and a therapeutic target that relates to the technical field of tumor biotherapy. This invention discloses a use of the non-coding RNA SNHG17 for the manufacture of a detection agent for predicting the drug resistance of fulvestrant. This invention also discloses the use of shRNA for inhibiting non-coding RNA SNHG17 expression. This shRNA can knockdown the expression of the non-coding RNA SNHG17 efficiently. In this way, the sensitivity of fulvestrant-resistant breast cancer cells can be increased. So this invention has good prospects for drug development.

    SYSTEM AND METHOD FOR ESTIMATING MOTION OF TARGET INSIDE TISSUE BASED ON SURFACE DEFORMATION OF SOFT TISSUE

    公开(公告)号:US20220130048A1

    公开(公告)日:2022-04-28

    申请号:US17571562

    申请日:2022-01-10

    Abstract: Provided is a system and method for estimating the motion of a target inside a tissue based on surface deformation of the soft tissue. The system consists of an acquisition unit, a reference input unit, two surface extraction units, a target position extraction unit, a feature calculation unit, and a target motion estimation unit. The method includes: the acquisition unit acquires an image Ii of the soft tissue; the surface extraction unit extracts a surface fi of the soft tissue from Ii; the reference input unit acquires a reference image Iref of the soft tissue; the surface extraction unit and the target position extraction unit respectively extract a reference surface fref of the soft tissue and a target reference position tref from Iref, the feature calculation unit calculates deformation feature Ψi of fi relative to fref, the target motion estimation unit estimates the target displacement based on Ψi and tref.

Patent Agency Ranking